TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.26
-0.27 (-4.80%)
At close: Jan 20, 2026, 4:00 PM EST
5.26
0.00 (0.00%)
After-hours: Jan 20, 2026, 4:00 PM EST
TriSalus Life Sciences Employees
TriSalus Life Sciences had 110 employees as of December 31, 2024. The number of employees decreased by 2 or -1.79% compared to the previous year.
Employees
110
Change (1Y)
-2
Growth (1Y)
-1.79%
Revenue / Employee
$365,518
Profits / Employee
-$643,891
Market Cap
262.81M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 110 | -2 | -1.79% |
| Dec 31, 2023 | 112 | 37 | 49.33% |
| Dec 31, 2022 | 75 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TLSI News
- 8 days ago - TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - Business Wire
- 5 weeks ago - TriSalus Life Sciences, Inc. (TLSI) Discusses Innovative Approaches for Thyroid Artery Embolization and Tumor-Targeted Therapies Transcript - Seeking Alpha
- 6 weeks ago - TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025 - Business Wire
- 2 months ago - TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™ - Business Wire
- 2 months ago - TriSalus Life Sciences, Inc. (TLSI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance - Business Wire
- 2 months ago - TriSalus Life Sciences, Inc. (TLSI) Discusses Pressure-Enabled Drug Delivery and Advances in Uterine Fibroid Embolization Transcript - Seeking Alpha
- 2 months ago - TriSalus Life Sciences to Participate in Upcoming Investor Conferences - Business Wire